Such et al stratified the risk in chronic myelomonocytic leukemia (CMML) based on cytogenetic findings. The authros are from multiple institutions in Spain.
Patient selection: chronic myelomonocytic leukemia (CMML)
Cytogenetic Result
Risk Level
normal karyotype
low
loss of Y chromosome
trisomy 8
high
monosomy chromosome 7 or del(7q)
complex karyotype (>=3 abnormalities)
any other pattern
intermediate
5-Year Survival
35%
26%
4%
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology
